Sun Pharma falls 6 pct on surprise inspection reports

Written by Reuters | Updated: Sep 11 2014, 17:03pm hrs
Sun PharmaSun Pharmaceutical Industries slumps as much as 6 percent, heading towards its biggest single day fall since March 16, 2012. (Reuters)
Sun Pharmaceutical Industries slumps as much as 6 percent, heading towards its biggest single day fall since March 16, 2012.

Ranbaxy Laboratories (RANB.NS) also fell as much as 6 percent.

Media reports say surprise inspection by U.S. drug regulator on its Halol plant in Gujarat.

A company spokesman said, "We have no comments to offer".

"Majority of the inspections taking place nowadays are surprise inspection," Motilal said in a note to its clients.

Must wait for the final audit report to come, the Motilal note adds.

Also, Sun Pharma recalled 200 vials of a cancer drug in July.

Separately, the U.S. FDA said in May that Sun Pharma's response to the import ban on its Karkhadi plant in Gujarat was inadequate.